This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

RadNet Announces Its Intention To Re-Price Its Senior Secured Term Loan And Raise An Additional $40 Million

LOS ANGELES, March 20, 2013 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 246 owned and operated outpatient imaging centers, today announced that it has begun a process to re-price its existing senior secured term loan under which, as of December 31, 2012, RadNet had approximately $349.1 million aggregate principal amount outstanding.

Additionally, as part of this transaction, RadNet is seeking to raise an additional $40 million under the same senior term loan ("Incremental Term Loan"). Proceeds from the Incremental Term Loan will be used to repay the existing amount outstanding under the revolving credit facility (which at December 31, 2012 was $33 million) and to fund fees, expenses and working capital.

RadNet intends to complete the transaction in April, 2013. However, there can be no assurance that RadNet will be able to complete the transaction on commercially reasonable terms or at all. Any such transaction is subject to market and customary closing conditions.

In connection with the marketing of the proposed re-pricing and Incremental Term Loan, RadNet releases the following reconciliation of trailing twelve month Adjusted EBITDA (1) to trailing twelve month Pro Forma Adjusted EBITDA (1), which incorporates certain adjustments related to events that have taken place within the last twelve months.
($ in Thousands)
 Trailing 12 Month Adjusted EBITDA (1) As Reported (2) $113,602
Pro Forma Adjustment for Acquisitions Completed in the Last 12 Months  9,090
Pro Forma Adjustment for the Buyout of Operating Leases Completed in the Last 12 Months  610
Adjustment for Loss of Business Associated with Hurricane Sandy  3,500
Adjustment for Salary Expense Paid in Q4 in Lieu of Future Salary Increases  1,000
Trailing 12 Month Pro Forma Adjusted EBITDA (1)  $127,802

(1) The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events that have taken place during the period.

Adjusted EBITDA and Pro Forma Adjusted EBITDA are reconciled to its nearest comparable GAAP financial measure. Adjusted EBITDA and Pro Forma Adjusted EBITDA are non-GAAP financial measures used as analytical indicators by RadNet management and the healthcare industry to assess business performance, and are measures of leverage capacity and ability to service debt. Neither Adjusted EBITDA nor Pro Forma Adjusted EBITDA should be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA and Pro Forma Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA and Pro Forma Adjusted EBITDA are not measurements determined in accordance with GAAP and are therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs